Journal article
The impact of medicare part D on medication treatment of hypertension
Y Zhang, JM Donohue, JR Lave, WF Gellad
Health Services Research | WILEY | Published : 2011
Abstract
Objective: To evaluate Medicare Part D's impact on use of antihypertensive medications among seniors with hypertension. Data Sources. Medicare-Advantage plan pharmacy data from January 1, 2004 to December 12, 2007 from three groups who before enrolling in Part D had no or limited drug benefits, and a comparison group with stable employer-based coverage. Study Design. Pre-post intervention with a comparison group design was used to study likelihood of use, daily counts, and substitutions between angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers (ARBs). Principal Findings. Antihypertensive use increased most among those without prior drug coverage: likelihood of use..
View full abstractGrants
Awarded by National Center for Advancing Translational Sciences
Funding Acknowledgements
This publication was supported by the National Center for Research Resources, National Institutes of Health, NIH Roadmap for Medical Research (grant no. KL2-RR024154-01), and the University of Pittsburgh's Graduate School of Public Health Computational and Systems Models in Public Health Pilot Program.During the study period, Dr. Zhang was also supported by NIMH RC1MH088510 and AHRQ R01HS018657.